Full-Time
Pharmaceutical Sales Representative
Prism Biotech
Prelaunch prescriber profiling and targeting
Compensation Overview
$87.4k - $118.7k/yr
Seattle, WA, USA
In Person
Bachelor's
 Sales & Account Management (1) |
|---|
Get referred to Prism Biotech
See people who can refer or advise you
- Demonstrated sales abilities, unless the candidate has a college degree.
- Ability to develop strategic long-term relationships with customers to help patients and achieve business results.
- Ability to communicate pharmacodynamics and other clinical evidence to physicians and clinical stakeholders.
- Strong alignment with the corporate values of putting the patient at the center, collaboration, relentless pursuit of excellence, and trust.
- Strong organizational and time management skills.
- Strong business acumen and ability to understand market opportunities.
- Execute the brand and sales strategy to demonstrate product value to key customers.
- Use knowledge of local market trends, institutions, and key customers to optimize the national strategy and drive territory-level business results.
- Execute established pharmaceutical sales team business and account plans to improve brand usage within key accounts.
- Collaborate with matrix team members to improve territory performance and elevate brand value.
- Use internal pharmaceutical sales resources, including market data and analysis, to shape territory business plans, drive business results, and impact patients.
- Use internal systems for call planning and recording call activity.
- Identify and pursue opportunities to improve organizational efficiency and processes.
- A college degree.
- Familiarity with databases, statistics, product lines, and current medical issues.
Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Merion Township, Pennsylvania
Founded
2019
Get referred to Prism Biotech
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ono paid an initial milestone in November 2025, proving partner monetization.
- Receptor.AI partnership on March 12, 2026 expands PRISM into AI-guided discovery.
- Eisai presented E7386 preclinical and Phase 1 results in 2026, strengthening credibility.
What critics are saying
- Servier terminated its collaboration and licensing agreement with PRISM BioLab in 2026.
- Boehringer Ingelheim agreement expired in 2026, shrinking partnered revenue optionality.
- PRISM depends on external partnerships; a pipeline failure would crush Japan-listed growth equity valuation.
What makes Prism Biotech unique
- PepMetics® targets intracellular PPIs and membrane proteins using orally available small molecules.
- Eisai and PRISM co-created E7386, validating PRISM’s chemistry in oncology.
- PRISM licenses platform discovery across pharma partners, not just single in-house programs.
Help us improve and share your feedback! Did you find this helpful?